Stay updated on CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.

Latest updates to the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page
- Check3 days agoChange DetectedThe study record history shows a new revision entry labeled v3.7.0, replacing the previous revision v3.6.6. This update reflects a metadata change to the record's revision history rather than to the study data itself.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page's Version History shows a new revision: v3.6.6 replaces the previous v3.6.5, representing a small update to the page’s versioning metadata.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry v3.6.5 was added to the record history, indicating an update to the page’s version history. The previous v3.6.4 entry was removed from the history.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision entry (v3.6.4) was added to the study record history, and the previous revision (v3.6.3) was removed. This reflects an administrative update to the record rather than changes to the study data.SummaryDifference0.1%

- Check81 days agoChange DetectedA new revision entry v3.6.3 has been added to the record history, indicating a site-wide interface update that supersedes the prior v3.6.2 revision. This reflects maintenance or UI changes rather than alterations to trial data.SummaryDifference0.1%

- Check89 days agoChange DetectedAn additional revision entry (v3.6.2) is added to the history, indicating an update to the study record. The older revision (v3.6.0) is removed from the history log.SummaryDifference0.1%

Stay in the know with updates to CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.